Women continue to have a higher risk of mortality and morbidity after coronary artery bypass grafting (CABG) compared with men, with no significant improvements seen over the last decade, a ...

BOSTON -- Adding fuel to the controversy of revascularization for left main disease, patients had better survival after coronary artery bypass grafting (CABG) surgery than percutaneous coronary ...

The Aga Khan University Hospital (AKUH) Pakistan has earned The Joint Commission’s Gold Seal of Approval for its heart bypass ...

Complement activation via C3 and C5 plays an important role in inflammation, vasoconstriction, vascular leakage, leukocyte activation, cardiac damage, and apoptosis. The inhibition of complement ...

CHICAGO — Monotherapy with ticagrelor (Brilinta, AstraZeneca) instead of aspirin showed no signal for benefit and similar bleeding risk 1 year after coronary artery bypass grafting (CABG) in the TiCAB ...

Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin alone, ...

Please provide your email address to receive an email when new articles are posted on . The price of CABG was not associated with adverse outcomes or CMS or patient rankings. Cost was higher at ...

Among patients who are already taking statins, giving additional doses in the hours before CABG isn’t worthwhile, the StaRT-CABG trial shows. The 30-day rate of MACCE (a composite of all-cause ...

Bypass surgery is a type of open-heart surgery. Surgeons may use several different types of bypass surgeries to repair or replace the heart. Open-heart surgery is an operation where surgeons repair or ...

For the prevention of new-onset atrial fibrillation (AF) after isolated coronary artery bypass graft (CABG) surgery, giving potassium supplements only when levels dropped below the lower limit of ...

John Ross may be Australia's longest surviving double bypass patient. Here's how has the cardiac operation has evolved over the past 50 years.

MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) failure among patients who undergo coronary artery bypass surgery, the ...